CN106457000A - 病毒性皮肤病的治疗 - Google Patents

病毒性皮肤病的治疗 Download PDF

Info

Publication number
CN106457000A
CN106457000A CN201580029943.XA CN201580029943A CN106457000A CN 106457000 A CN106457000 A CN 106457000A CN 201580029943 A CN201580029943 A CN 201580029943A CN 106457000 A CN106457000 A CN 106457000A
Authority
CN
China
Prior art keywords
skin
viral
water
herpes
extract comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580029943.XA
Other languages
English (en)
Chinese (zh)
Inventor
埃里卡·N·安格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ixcela Inc
Original Assignee
Counterpoint Health Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Counterpoint Health Solutions Inc filed Critical Counterpoint Health Solutions Inc
Publication of CN106457000A publication Critical patent/CN106457000A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201580029943.XA 2014-06-11 2015-06-11 病毒性皮肤病的治疗 Pending CN106457000A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462010860P 2014-06-11 2014-06-11
US62/010,860 2014-06-11
PCT/US2015/035384 WO2015191891A1 (en) 2014-06-11 2015-06-11 Treatment of virus-based diseases of the skin

Publications (1)

Publication Number Publication Date
CN106457000A true CN106457000A (zh) 2017-02-22

Family

ID=54834337

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580029943.XA Pending CN106457000A (zh) 2014-06-11 2015-06-11 病毒性皮肤病的治疗

Country Status (6)

Country Link
US (3) US10034908B2 (enExample)
EP (1) EP3154637A4 (enExample)
JP (1) JP2017517543A (enExample)
CN (1) CN106457000A (enExample)
CA (1) CA2951881C (enExample)
WO (1) WO2015191891A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017210380A1 (en) * 2016-06-01 2017-12-07 Excision Biotherapeutics, Inc. Compositions and methods of treatment for lytic and lysogenic viruses
CN107184886B (zh) 2017-05-16 2018-06-19 贾洪章 抗病毒中药组合物及其制备方法和用途
US11065289B1 (en) 2020-12-21 2021-07-20 Elena Sanchez Alonso Substance and method for the treatment of poxvirus
US12485153B1 (en) 2021-06-16 2025-12-02 Elena Sanchez Alonso Substance for the treatment of poxvirus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101023972A (zh) * 2007-03-26 2007-08-29 赵昱 蒲公英中酚酸类有效部位治疗口腔溃疡的用途
CN102068611A (zh) * 2009-11-19 2011-05-25 谢菊荣 一种治疗急性疱疹的外用药
CN103800485A (zh) * 2014-03-12 2014-05-21 马丽 一种治疗单纯疱疹病毒性角膜炎的中药制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11103832A (ja) * 1997-09-25 1999-04-20 Sho Ki タンポポ茶葉の製造方法、タンポポ茶葉、抗ウイルス剤
CN1246029C (zh) 2002-05-28 2006-03-22 杨毓龙 治疗带状疱疹的药物
CN100998657A (zh) * 2006-12-28 2007-07-18 江蕾 一种治疗带状疱疹的内服中药
CN101181366B (zh) * 2007-11-26 2010-06-16 仲海崑 一种内服加外用治疗带状疱疹的中药组合物
CN101391044A (zh) * 2008-11-13 2009-03-25 牛德兴 一种治疗带状疱疹、单纯疱疹等病毒性疾病的外用中药及其制备方法
WO2011044122A1 (en) * 2009-10-05 2011-04-14 Steven Charles Roberts Compositions and methods of treatment that include plant extracts
CN102961521B (zh) * 2012-12-11 2014-06-11 王正艳 一种治疗单纯疱疹病毒性角膜炎的药物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101023972A (zh) * 2007-03-26 2007-08-29 赵昱 蒲公英中酚酸类有效部位治疗口腔溃疡的用途
CN102068611A (zh) * 2009-11-19 2011-05-25 谢菊荣 一种治疗急性疱疹的外用药
CN103800485A (zh) * 2014-03-12 2014-05-21 马丽 一种治疗单纯疱疹病毒性角膜炎的中药制剂

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘冰: "《中医护理学》", 31 August 2007 *
曾宪策: "《临床常用中药400种》", 30 June 2012 *
顾家富: "《蒲公英对带状疱疹的疗效》", 《中国实用医刊》 *

Also Published As

Publication number Publication date
US10213468B2 (en) 2019-02-26
EP3154637A1 (en) 2017-04-19
JP2017517543A (ja) 2017-06-29
EP3154637A4 (en) 2018-02-07
US10034908B2 (en) 2018-07-31
CA2951881A1 (en) 2015-12-17
WO2015191891A1 (en) 2015-12-17
US20180296620A1 (en) 2018-10-18
US20150359833A1 (en) 2015-12-17
CA2951881C (en) 2020-12-29
US10220066B2 (en) 2019-03-05
US20180296619A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
Mustafa et al. Herpes simplex virus infections, Pathophysiology and Management
Stiles Feline herpesvirus
Schiffer et al. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection
US10213468B2 (en) Treatment of virus-based diseases of the skin
Nikkels et al. Treatment of mucocutaneous presentations of herpes simplex virus infections
Stiles Feline herpesvirus
Fiorito et al. Clinical improvement in feline herpesvirus 1 infected cats by oral low dose of interleukin-12 plus interferon-gamma
Pan et al. Inhibitory activity and mechanism of silver nanoparticles against herpes simplex virus type 1
Collins et al. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice
JP2005510490A (ja) Ｈｓｖ−１およびｈｓｖ−２の複製を阻止するための抗ｈｓｖ薬および抗ｈｓｖ活性を有する物質を製造する方法
CN107073057A (zh) 含有朝鲜中井淫羊藿提取物作为活性成分的抗病毒组合物
Shinde et al. Revisiting the therapeutic potential of homeopathic medicine Rhus Tox for herpes simplex virus and inflammatory conditions
WO1991007969A1 (en) Use of caffeine in the treatment of herpes simplex virus infections
CA2795334A1 (en) Agent for prophylactic and therapeutic treatment of herpes infections
EP4196099B1 (de) Diphenylderivate für die verwendung in der therapie von viruserkrankungen, insbesondere corona-infektionen, insbesondere covid-19
US20240174986A1 (en) Mutant herpesvirus and vaccine compositions
CN104771384A (zh) 紫草素的医药用途
KR102781686B1 (ko) 청색광을 이용한 바이러스를 예방 및 치료하는 방법
WO2023201882A1 (zh) 香菇多糖在治疗新型冠状病毒感染中的应用
Al-Khayri et al. Inhibitory effect on acute herpes and prevention of postherpetic neuralgia in herpes simplex virus-1-infected mice using a plant extract Ricinus communis
Bhattacharya et al. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines
US10080761B2 (en) Method for treating recurring skin and mucous membrane diseases caused by HSV-1 and HSV-2
DE19940748A1 (de) Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
Bondarieva et al. Market research D06B B antiviral drugs: A rational approach to the treatment of herpes-virus infections
JPH08268901A (ja) ヘルペスウイルスに起因するウイルス感染症再発予防剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170222

WD01 Invention patent application deemed withdrawn after publication